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Ddysfunction increases the overall hazard for death or trans-
plant, and most deaths are sudden or due to heart failure.
Morbidity is substantial, with a high incidence of tachy-
arrhythmia, surgical or catheter intervention, and pace-
maker insertion. Tachyarrhythmia is a particular problem
for TGA-atrial switch cases because it occurs significantly
earlier than in ccTGA cases. However, moderate to severe
SRV dysfunction, TR, and functional impairment are rela-
tively rare up to 40 years. Risk stratification for sudden car-
diac death and the identification of suitable strategies to
manage SRV impairment will be key to improving survival
in the future. In view of the high burden of SRV impairment,
an early aggressive strategy aimed at anatomic repair may
be warranted in the patients with ccTGA who require cor-
rective surgery for coexistent lesions. For the asymptomatic
patient with uncomplicated ccTGA, there is insufficient
adult follow-up data to comment on whether an anatomic
repair strategy is better than conservative management.
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Dr Shunji Sano (Okayama, Japan). There is always debate on
whether the morphologic RV supports the systemic circulation for
the patient’s entire life or not. The American College ofdiovascular Surgery c Volume 145, Number 6 1501
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DCardiology/American Heart Association guidelines show that ven-
tricular dysfunction seems to be related to systemic AV valve re-
gurgitation. In the absence of associated congenital anomalies,
primary RV failure is uncommon. Abnormality of the systemic
AV valve is Ebstein-like malformation in 90% of the patients. In
your series in the adult group, only 4 patients had Ebstein’s.
From your data, mortality is low with survival of 90% for
TGA-atrial switch and 84% for ccTGA. However, cumulative
mortality at 40 years from birth is 68% for TGA-atrial switch
and 67% for ccTGA. This means most of the deaths in these pa-
tients occur in the pediatric age, and in the patients who survived
to adult age, mortality is low with good RV function.
Do you have any data of TR and RV impairment of ccTGA in
the pediatric age population, and what was the reason of death
of these patients after TGA-atrial switch and ccTGA in the pediat-
ric age population?
Dr Dobson. The main aim of this study was to look at outcomes
in the adult patients who were cared for by the adult congenital
heart disease service. In terms of causes of death in the pediatric
population, we didn’t assess this in detail. Furthermore, I have lim-
ited data regarding the severity of TR and systemic RV impairment
as estimated from echocardiography or MRI in patients before the
age of 18 years.
However, one can make some deductions. A significant number
of the pediatric deaths occurred in association with the initial re-
pair and early postoperative course, and most of these were in
the late 1970s or early 1980s. SRV failure also was a significant
problem: Five patients in the pediatric population subsequently
went on to have a successful double switch procedure, and 1 pa-
tient required cardiac transplantation after unsuccessful PA band-
ing. The other cause of mortality in the pediatric patients was
sudden cardiac death. This raises the question of how to prevent
deaths due to SRV failure.
We know that as patients become older it is difficult to train the
morphologic LV in preparation for an anatomic repair. Therefore,
patients should be prepared for this at a young age, really as soon
as it has become evident that they have significant TR or signifi-
cant SRV failure. Professor Vouhe in Paris has published some fas-
cinating work on applying a prophylactic PA band to all patients
from birth with ccTGA. The reason behind this is to maintain
physiologic training of the LVand, in theory, to be able to offer an-
atomic repair to all patients with ccTGA should they require it.
The key role of any research in this group is to try and identify
a strategy that promptly identifies and intervenes in those patients
at high risk of SRV failure, while at the same time recognizing that
there are other patients who will do well with a more conservative
approach.
Dr Sano. Your freedom from arrhythmia at 40 years was 0.51
for TGA-atrial switch and 0.93 for ccTGA. There is a discrepancy
between TGA-atrial switch and ccTGA. Most of the arrhythmia in
those with TGA-atrial switch was atrial tachyarrhythmia, and most
of your atrial switch procedures were Mustard. Therefore, the rea-
son of the arrhythmia is due to late complication of Mustard rather
than RV dysfunction. Is the rate of arrhythmia the same in the Sen-
ning and Mustard groups?
Dr Dobson. The key thing is that the Senning group was
smaller. I don’t have the exact figures at hand, but I will find it
for you later. If one looks at the absolute values, certainly Mustard1502 The Journal of Thoracic and Cardiovascular Surcases accounted for most of the burden of tachyarrhythmia in the
TGA-atrial switch cohort. Of the 21 patients in the atrial switch co-
hort with documented tachyarrhythmia, only 2 underwent Senning
repair; the rest underwent Mustard. However, the a smaller number
of patients underwent Senning, accounting for only one fifth of the
atrial switch cases, and subsequent analysis demonstrated that
there was no statistically significant difference in freedom from
tachyarrhythmia between the 2 groups, with a P value of .892 as
estimated by the log-rank test: this data set is therefore underpow-
ered in this respect.
However, when one compares freedom from tachyarrhythmia
between the TGA-atrial switch cohort and the ccTGA cohort
you are absolutely correct, there were higher rates of arrhythmia
in TGA-atrial switch cases compared with ccTGA cases. My
own feeling is that this reflects the extensive atrial scar tissue
that has occurred as a result of the initial surgery, leading to a pro-
pensity for atrial macro-reentrant tachycardia.
Dr Sano. So that means if you perform a Senning operation,
most of these arrhythmias will be avoided. Recent reports from
many centers show a 20-year survival of more than 70% to 80%
after the double switch, and the Fontan operation is now adopted
in many cases rather than complex intracardiac repair, with a 10-
to 20-year survival of 70% to 90%, and the reintervention after
Fontan is low.
We recently reported our results of ccTGA. Although the mean
follow-up is only 10 years, in a double switch with the Senning ar-
terial switch group, there was no mortality. In the Senning–Rastelli
group, wemeasured the length between interventricular septum and
aorta, and all early and late mortality came from the group with
a long distance between the interventricular septumand aorta. There
was no mortality in the patients with the short distance. Therefore,
we do a Fontan operation in the long distance group and a double
switch in the short distance group. I hope the long-term survival
will improve using different techniques in individual patients.
Dr John Foker (Minneapolis, Minn). This is a valuable study,
because there are a number of these patients. I did 50 atrial baffle
procedures (modified Shumacker) for simple transposition. They
all left the hospital, 2 or 3 died later suddenly, but many of them
are doing well, including 1 woman who recently gave birth to
a child with TGA.
My question concerns the RV dysfunction. These patients un-
derwent operation at a time when myocardial protection was rudi-
mentary at best and was, in essence, clamp and go, with the RVout
under the hot lights. Do you think the RV dysfunction, when you
see it, could be due mostly to this poor myocardial protection
rather than any intrinsic inability of the RV to serve as the systemic
ventricle? If so, when you looked at these hearts, would you see
subendocardial fibrosis in those that were failing?
Dr Dobson. One would expect that more primitive myocardial
protection techniques would result in greater myocyte necrosis in
the SRV and consequent impairment. However, it is uncertain
whether this is permanent or there is potential for recovery. There
are clearly many other factors that could contribute to the develop-
ment of SRV failure, not least because we know that some patients
with isolated ccTGAwho have never proceeded to surgery some-
times develop significant cardiac failure. To answer your question,
one would need a larger study population. One could then compare
outcomes between patients who had been repaired in the currentgery c June 2013
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Dera with all the advantages of modern techniques of myocardial
protection and patients who had been repaired 20 or 30 years
ago when such technology was less advanced. Multivariate analy-
sis would then allow adjustment for confounding variables and
provide insight into the effect of cardiopulmonary bypass in pre-
dicting those who will go on to develop late systemic RV
impairment.
In answer to the second part of your question, subendocardial
fibrosis is something that is currently difficult to assess by MRI.
Even with late gadolinium enhancement, you are unlikely to be
able to distinguish whether someone definitely has fibrosis. There
is some interesting work looking at the use of MRI edema se-
quences for this purpose. It would be a fascinating study to try
and objectively assess the amounts of fibrosis in SRVs and then
compare these with the era of surgical repair. But I don’t have
the data for that in this study. The other problem is that many of
these patients require permanent pacing, which precludes assess-
ment by MRI at least in the current era.
Dr Gerhard Ziemer (Chicago, Ill). I understand that you have
to simplify your conclusions in a talk like this, but I have to make 2
remarks.The Journal of Thoracic and CarFor atrial repair of TGA, you cannot really put patients with
and without VSD into 1 group and give them a single incidence
for arrhythmias. The same is true for RV function, because you
may have a different cause of RV function impairment, either
secondary to TR or preceding it. This relates to VSD closure
or no VSD closure. So at least in your article you should
discuss this.
My second point relates to you just comparing arrhythmia in-
cidence for ccTGA with arrhythmias in normal transposition.
But you only can compare them for their types of arrhythmias:
Patients post–atrial switch for TGA mainly have atrial arrhyth-
mias and patients post-ccTGA have sudden AV block with
and without surgery. So there is really a different mechanism
of late failure, but I understand the simplification in your
presentation.
Dr Dobson. Thank you.
Dr Craig Smith (New York, NY). This study is a sobering re-
minder that when we are dealing with a population with such
a long life expectancy, the duration of follow-up required to answer
any of these questions is long, and I look forward to the 40-year
follow-up.diovascular Surgery c Volume 145, Number 6 1503
